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Considerable experimental and clinical data indicate that sex has an important influence on
cardiovascular physiology and pathology. This report integrates selected literature with new
data from the Women’s Ischemia Syndrome Evaluation (WISE) on vascular findings in
women with ischemic heart disease (IHD) and how these findings differ from those in men.
A number of common vascular disease-related conditions are either unique to (e.g.,
hypertensive disorders of pregnancy, gestational diabetes, peripartum dissection, polycystic
ovarian syndrome, etc.) or more frequent (e.g., migraine, coronary spasm, lupus, vasculitis,
Raynaud’s phenomenon, etc.) in women than men. Post-menopausal women more frequently
have many traditional vascular disease risk conditions (e.g., hypertension, diabetes, obesity,
inactivity, and so on), and these conditions cluster more frequently in them than men.
Considerable evidence supports the notion that, with these requisite conditions, women
develop a more severe or somewhat different form of vascular disease than men. Structurally,
women’s coronary vessels are smaller in size and appear to contain more diffuse atheroscle-
rosis, their aortas are stiffer (fibrosis, remodeling, and so on), and their microvessels appear to
be more frequently dysfunctional compared with men. Functionally, women’s vessels
frequently show impaired vasodilator responses. Limitations of existing data and higher risks
in women with acute myocardial infarction, need for revascularization, or heart failure create
uncertainty about management. A better understanding of these findings should provide
direction for new algorithms to improve management of the vasculopathy underlying IHD in
women. (J Am Coll Cardiol 2006;47:30S–5S) © 2006 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.09.023Cardiology Foundation
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Considerable data indicate that sex has an important
nfluence on cardiovascular (CV) physiology and pathol-
gy (1,2). The purpose of this report is to critically review
elected clinical and experimental data, while integrating
ew findings from the Women’s Ischemia Syndrome
valuation (WISE), on vascular findings related to isch-
mic heart disease (IHD) in women and how these
ndings differ from those in men. The hypothesis is that
omen with IHD have evidence for a more severe or
ifferent form of vascular disease compared with men.
hese data should help to better define the vasculopathy
nderlying IHD as it occurs in women and suggest
irection for new algorithms to improve detection and
anagement at an early stage.
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ender-related differences in clinical findings linked to
ascular disease are best illustrated by risk conditions unique
o women (Table 1). In the peripartum period, some
xamples include the hypertensive disorders of pregnancy
e.g., preeclampsia and eclampsia), proximal coronary artery
nd aortic root dissection, as well as gestational diabetes and
elivering a thin baby. For example, the relatively common
5% to 10% of term pregnancies) hypertensive disorders of
regnancy are associated with significant increase in IHD
ater in the mother’s life (3,4). For the relatively rare
oronary or aortic dissection, the IHD risk is obvious. But
estational diabetes, occurring in 2% to 9% of pregnancies,
esults in sustained glucose intolerance or diabetes in most
ases and implications for vascular disease that are not as
bvious (5,6). Mothers who once gave birth to thin babies
re also at increased risk for IHD (7). It has been suggested
hat these mothers, like their children, have impaired
ascular function, which was already present during the
rocess of implantation interfering with placental function
eading to low birth weight. Many of these conditions have
een linked with oxidative stress, endothelial dysfunction,
nflammation, insulin resistance, defective angiogenesis, and
yslipidemia (8–11). Perhaps these conditions explain, at
east in part, some non-genetic factors in a family history of
V disease that play a role in the lifelong risk for IHD in
omen.
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February 7, 2006:30S–5S Vasculopathy of Women With IHDExamples of risk conditions unique to women unrelated
o the peripartum period but linked to hypertension, obe-
ity, insulin resistance, and IHD include polycystic ovarian
yndrome, hypoestrogenemia of central origin, and estrogen
eplacement, which are reviewed elsewhere in this supple-
ent (12) (Table 1). Additionally, women have higher
requencies of vasculitis (e.g., Takayasu’s arteritis, temporal
rteritis, rheumatoid vasculitis, lupus vasculitis, polymyalgia
heumatica, etc.) compared with men.
Women also have somewhat different clinical findings
hat relate to pathophysiology of IHD than male counter-
arts. The woman with IHD often is older, has a greater
isk factor burden, and more functional disability (12,13).
ging attenuates many estrogen-related potentially benefi-
ial vascular responses (2) including endothelial progenitor
ells (EPCs) (14) and coronary microvascular function in
he WISE (15). Experimental models have linked sex
ormones and other risk conditions (e.g., hypertension,
iabetes, and so on) to IHD in women (2). Briefly, high
strogen levels before menopause and decreasing estrogen
nd progesterone levels after menopause are believed to
nfluence IHD in women. Estrogen exerts effects via recep-
ors abundant in vascular tissue to transduce signals regu-
ating expression of many genes, and it also has non-
enomic actions. Variations in plasma sex hormones and
eceptor genes, acting with endothelial and vascular smooth
uscle factors, are potential links to the differences in
ascular structure and function that contribute to both
able 1. The Vasculopathy of Women With IHD: Risk
onditions Versus Men
raditional risk conditions
Higher prevalence in postmenopausal women
More frequent clustering
When present, higher level (e.g., if hypertensive, higher BP,
higher LDL, and so on)
Older age
More frequent vasculitis (e.g., lupus, temporal arteritis, Takayasu’s,
and so on)
onditions unique to women
Peripartum
Hypertensive disorders of pregnancy
Gestational diabetes
Delivering a thin baby
Coronary or aortic root dissection
Polycystic ovarian syndrome
Hypoestrogenemia of hypothalamic origin
Hormone replacement therapy
Others
Abbreviations and Acronyms
ACS  acute coronary syndrome
CAD  coronary artery disease
CV  cardiovascular
EPC  endothelial progenitor cell
IHD  ischemic heart disease
WISE  Women’s Ischemia Syndrome EvaluationwP  blood pressure; IHD  ischemic heart disease; LDL  low-density lipoprotein.eterogeneity among women and gender differences in
HD.
LTERATIONS IN VASCULAR STRUCTURE
arge artery structure appears different in women (Table 2),
llustrated by the fact that their coronary arteries are smaller
han men independent of body size (16). Changes in artery
ize (e.g., remodeling) occur in response to physiologic (e.g.,
xercise) or pathologic conditions (e.g., atherosclerosis,
ypertension, and so on). Female vessels uniquely undergo
emodeling during and after pregnancy. Traditionally, this
as been considered physiologic remodeling, but, in the
resence of peripartum conditions linked with IHD (e.g.,
oronary dissection, thin babies, gestational diabetes, and so
n), this may not be the case. Recently, potentially patho-
ogic gender-related differences in remodeling have been
escribed in cardiac transplant recipients and transgender
atients.
Female hearts transplanted to women show little change
n coronary artery size over time, but, when transplanted to
en, they show progressive coronary enlargement indepen-
ent of body size and left ventricular hypertrophy (17). A
ink between arterial size and sex hormones is supported by
tudies of transsexuals where brachial artery size in genetic
en taking estrogens is smaller compared with control men
18,19). Genetic women taking androgens have larger
rteries than control women (20). Androgen-deprivation
herapy in genetic men is associated with smaller artery size
ompared with control men (21). These findings imply that
ex hormones have different effects on arterial remodeling
ith androgens causing enlargement (e.g., positive remod-
ling). Positive remodeling may be a marker of vascular
njury (22–24), and perhaps such injury could explain the
igh event rate observed among women with non-
bstructive coronary angiographic findings in the WISE
25). Also, larger brachial artery size was associated with
ore angiographic evidence of coronary artery disease
CAD) (26). Brachial artery size, readily measured non-
nvasively by ultrasound, may be helpful to identify women
ith early atherosclerosis.
Postmenopausal women more frequently have atheroscle-
osis risk conditions (e.g., hypertension, diabetes, metabolic
yndrome, obesity, and so on) than men, and these condi-
ions more frequently cluster in women. Adding the risk
onditions unique to women noted previously would predict
ore atheroma burden in their smaller coronary arteries.
ven with apparently “normal” coronary angiography, dif-
use atherosclerosis may result in abnormal resistance lim-
ting myocardial flow (27) with deleterious consequences for
evascularization (28,29). Study of transplant donor hearts
uggest coronary atherosclerosis without apparent flow lim-
ting stenoses has a similar prevalence comparing men and
omen (30). These findings support the notion that severe
oronary atherosclerosis may alter structure in many of these
omen without recognition by angiography.
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Vasculopathy of Women With IHD February 7, 2006:30S–5SStructural changes in large arteries from aging and
therosclerosis increase arterial stiffness (31). In diabetic
omen, but not men, age-related stiffening of the aorta
ccurs (32). Alterations in large artery stiffness were ob-
erved in a sample of women from the WISE compared
ith age- and body mass index-matched control women
33). In other postmenopausal women with CAD, brachial
ulse pressure, another measure of arterial stiffness, was
ssociated with CAD progression, independent of risk
actors or hormone replacement (34). In the WISE, pulse
ressure was an independent predictor of CAD severity and
linical outcomes (35). Non-invasive measures of arterial
tiffness may be useful to estimate the structural conse-
uences of atherosclerosis in post-menopausal women and
ay provide insight into the effect of therapies on stiffness
nd adverse outcomes.
Microvascular structural damage secondary to aging,
ypertension, diabetes, left ventricular hypertrophy, and
ther processes is also likely to be important in women. To
his end, retinal microvascular abnormalities have been
inked to past blood pressure (36), inflammation, and
ndothelial dysfunction (37). Such microvascular abnormal-
ties predict IHD outcomes in women but not men (38).
hus, retinal microvascular structural alterations allow non-
nvasive investigation of systemic vascular pathology.
ASCULAR FUNCTION
unctional alterations as changes in vascular reactivity also
uggest a more severe disease in women implicating both
ndothelium and smooth muscle (Table 2). Sex hormones
xert effects on vascular reactivity via endothelium and also
irectly on smooth muscle (2). Various mechanisms are
nvolved, ranging from gender-specific influences on nitric
xide synthase gene (39) to sex-hormone–related differences
n L-type voltage-gated Ca2-activated K channels (2,40)
nd also include effects on vascular repair (41). Because
omen’s vessels spend considerable time under widely
arying hormonal influences (e.g., puberty, pregnancy, pe-
ipartum, and menopause), their vessels may be pro-
able 2. The Vasculopathy of Women With IHD: Coronary
tructure and Function Versus Men
tructural findings
Macrovessels and microvessels
Smaller size
Increased stiffness (fibrosis, remodeling, and so on)
More diffuse disease, erosion rupture
Microemboli, rarefaction (drop out), disarray, and so on
unctional findings
Macro- and microvessels
Endothelial dysfunction
Smooth muscle dysfunction (Raynaud’s, migraine, CAS)
Inflammation
Plasma markers
Vasculitis (Takayasu’s, rheumatoid, SLE, CNSV, giant cell,
and so on)d
AS  coronary artery spasm; CNSV  central nervous system vasculitis; IHD 
schemic heart disease; SLE  systemic lupus erythematosus.rammed for more severe functional alterations compared
ith men.
ole of coronary endothelial dysfunction. More than half
he women tested with acetylcholine in the WISE had
oronary endothelial dysfunction, which independently pre-
icted adverse outcomes (42). The risk conditions present in
omen, alone or in clusters, increase oxidative stress to
njure endothelium of both large and small vessels in varying
egrees (43,44). In large arteries of women presenting with
hest discomfort, endothelial dysfunction is a marker for
arly atherosclerosis before structural changes to the vessel
all are appreciated by angiography (45). Vascular injury
esulting in endothelial dysfunction has been linked to
ositive remodeling of large coronary arteries without flow-
imiting lesions (22). Endothelial dysfunction of the micro-
asculature has the potential to limit myocardial perfusion
45,46).
Normal endothelial repair processes may be adequate for
his injury, but over time, repair processes may become
nadequate for many reasons (e.g., loss of estrogen, over-
helming oxidative stress as associated with metabolic
yndrome, hypertension, obesity, aging, and so on). Recent
vidence indicates that bone-marrow–derived EPCs are
mportant in vascular repair, and estrogen increases circu-
ating EPCs by antiapoptotic effects (41). Circulating EPCs
ecome depleted in individuals with multiple risk conditions
nd aging (41). Considering the density of risk conditions
mong women presenting with suspected IHD in the
ISE, a reasonable hypothesis would be that such women
re more vulnerable to continuing injury leading to more
therosclerosis than those without high densities of risk
actor conditions. Some female unique conditions (e.g.,
regnancy-associated hypertension or metabolic disorders,
nd so on) are also associated with endothelial dysfunction
nd make such women more vulnerable to develop IHD.
inally, because clinical manifestations of IHD in women
resent 10 or more years later in life than men, this occurs
t time when aging likely has powerful effects on supply and
uality of EPCs. Thus women, at this later stage of life,
ould be less capable of vascular repair, which could
ontribute to poor outcomes compared with men whose
oronary vessels were preconditioned at an age when they
ere more capable of vascular repair.
ole of vascular smooth muscle dysfunction. Manifesta-
ions suggesting alterations of vascular smooth muscle
unction are more frequent in women than men (e.g.,
oronary artery spasm, Raynaud’s phenomenon, and mi-
raine), and both coronary spasm and migraine have been
inked with IHD. Impaired smooth muscle relaxation has
lso been suggested as a marker for atherosclerosis (47).
oronary flow reserve attenuation, as observed in many of
he WISE women with intracoronary adenosine (15,48–
0), suggests impaired microvascular smooth muscle relax-
tion. Positron emission tomographic scanning results in a
ISE subgroup without epicardial CAD suggest that the
istribution of this microvascular defect is heterogenous
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February 7, 2006:30S–5S Vasculopathy of Women With IHD51), and P31 cardiac magnetic spectroscopy results docu-
ent high-energy phosphate depletion as seen with isch-
mia (52). Hypertension, diabetes, obesity, and other con-
itions found more frequently in postmenopausal women
han men are associated with microvascular dysfunction.
ut atherosclerosis risk conditions account for 20% of the
ariability in coronary flow reserve, indicating that other
actors, as yet to be identified, influence microvascular
unction (15).
Previous studies have also documented gender-related
ifferences in skin flow responses to provocative maneuvers
43) and in endothelial nitric oxide production in skin
icrovasculature (44). Estrogen improves endothelial func-
ion, but menopause is associated with abnormal endothelial
unction in coronary microvessels. Estrogens, but not pro-
estogens, antagonize the effect of menopause (53). So
omen are primed to have microvascular dysfunction,
hich has been suggested as a cause for ischemia without
ow-limiting epicardial stenoses. Also, microvascular spasm
ay cause ischemia, and most of these patients are women
54–56). Recently, it has been suggested that endothelial-
ndependent microvascular dysfunction to adenosine is an
ndependent predictor of adverse outcomes in angina pa-
ients (57). These examples indicate that microvascular
ysfunction has the potential to evoke angina-like symp-
oms and cardiac ischemia and is linked with adverse
utcomes.
elative roles of endothelial versus smooth muscle dys-
unction and large vessels versus microvessels. Consid-
rable evidence implicates the coronary microcirculation,
long with large vessel atheroma, to explain findings in IHD
58). This includes wide variability in effort tolerance over
ime (a frequent finding in women), large scatter between
tenosis severity and flow reserve (59), reduced flow re-
ponses to stress in regions perfused by non-stenotic vessels
60), variability in outcome after successful percutaneous
ntervention (61), the 25% of women with acute coronary
yndrome (ACS) who have no flow-limiting stenosis (62),
he predictive value of brain natriuretic peptide and
-reactive protein for adverse outcomes in women with
CS (63), and pathologic findings of plaque erosion with
icrovascular embolization in women dying with ACS (64).
In summary, considerable evidence indicates that the
arge and small coronary vessels of women with IHD may
e more diseased compared to men (Tables 1 and 2). Under
hese circumstances, the consequences of a given ischemic
pisode would be expected to be altered in an unfavorable
anner. In such women, an area of ischemic injury may not
e limited because usual vasorelaxation required for collat-
ral function is abnormal. This theory could help explain
hy women tolerate ACS poorly compared with men and
hy subsequent heart failure, for example, is not only more
requent but also more lethal in women than men. The
oregoing should help the reader place the vascular findings
rom the WISE and other studies into a meaningful clinical
erspective (Tables 1 and 2).eprint requests and correspondence: Dr. Carl J. Pepine, Divi-
ion of Cardiovascular Medicine, University of Florida College of
edicine, Gainesville, Florida 32610. E-mail: pepincj@medicine.
fl.edu.
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